Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: New regulators and its implications

86Citations
Citations of this article
158Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the past years, cardiac mortality has decreased, but cardiac diseases are still responsible for millions of deaths every year worldwide. Bone-marrow mesenchymal stem cells (BMSCs) transplantation may be a promising therapeutic strategy because of its capacity to differentiate into cardiac cells. Current research indicates that chemical substances, microRNAs, and cytokines have biological functions that regulate the cardiomyocytes differentiation of BMSCs. In this review, we chiefly summarize the regulatory factors that induce BMSCs to differentiate into cardiomyocytes.

Cite

CITATION STYLE

APA

Guo, X., Bai, Y., Zhang, L., Zhang, B., Zagidullin, N., Carvalho, K., … Cai, B. (2018, February 26). Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: New regulators and its implications. Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13287-018-0773-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free